794 results match your criteria: "Centre for Oncology[Affiliation]"

Region-selective and site-specific glycation of influenza proteins surrounding the viral envelope membrane.

Sci Rep

August 2024

Centre for Oncology, Radiopharmaceuticals and Research, Biologic and Radiopharmaceutical Drugs Directorate, Health Canada, Ottawa, ON, K1A 0K9, Canada.

Analysis of protein modifications is critical for quality control of therapeutic biologics. However, the identification and quantification of naturally occurring glycation of membrane proteins by mass spectrometry remain technically challenging. We used highly sensitive LC MS/MS analyses combined with multiple enzyme digestions to determine low abundance early-stage lysine glycation products of influenza vaccines derived from embryonated chicken eggs and cultured cells.

View Article and Find Full Text PDF

This work presents the application of an Encoder-Decoder convolutional neural network (ED-CNN) model to automatically segment COVID-19 computerised tomography (CT) data. By doing so we are producing an alternative model to current literature, which is easy to follow and reproduce, making it more accessible for real-world applications as little training would be required to use this. Our simple approach achieves results comparable to those of previously published studies, which use more complex deep-learning networks.

View Article and Find Full Text PDF

Endometrial cancer (EC), one of the most prevalent carcinomas in females, is associated with increasing mortality. We identified the CHD4 R975H mutation as a high-frequency occurrence in EC patients through a comprehensive survey of EC databases. Computational predictions suggest that this mutation profoundly impacts the structural and functional integrity of CHD4.

View Article and Find Full Text PDF

Somatic copy number alterations (CNAs) are major mutations that contribute to the development and progression of various cancers. Despite a few computational methods proposed to detect CNAs from single-cell transcriptomic data, the technical sparsity of such data makes it challenging to identify allele-specific CNAs, particularly in complex clonal structures. In this study, we present a statistical method, XClone, that strengthens the signals of read depth and allelic imbalance by effective smoothing on cell neighborhood and gene coordinate graphs to detect haplotype-aware CNAs from scRNA-seq data.

View Article and Find Full Text PDF

Development of a highly sensitive platform for protein-protein interaction detection and regulation of T cell function.

Proc Natl Acad Sci U S A

August 2024

Department of Forensic Pathology and Science, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8523, Japan.

Article Synopsis
  • * The IFNARRS system is significantly more sensitive than the popular NanoBiT system for detecting these interactions and can identify low levels of cytokines like IFNγ or IL-2.
  • * This system can also detect other cytokines by using extracellular domains from their respective receptors, enhancing cell responses to signals from activated T cells.
View Article and Find Full Text PDF

ERCC2 mutations alter the genomic distribution pattern of somatic mutations and are independently prognostic in bladder cancer.

Cell Genom

August 2024

School of Biomedical Sciences, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong SAR, China; Centre for Oncology and Immunology, Hong Kong Science Park, Hong Kong SAR, China; Centre for PanorOmic Sciences, The University of Hong Kong, Pokfulam, Hong Kong SAR, China. Electronic address:

Article Synopsis
  • Excision repair cross-complementation group 2 (ERCC2) is key for DNA repair, and mutations in this gene are found in about 10% of bladder cancer cases, potentially indicating how well patients respond to cisplatin therapy.
  • * In a study, mutations in ERCC2 were found to independently predict prognosis for bladder cancer and significantly change the mutation patterns in the genome, leading to specific mutation hotspots.
  • * Researchers used these findings to create a machine learning model that may help predict harmful ERCC2 mutations, aiming to improve treatment strategies for bladder cancer patients.
View Article and Find Full Text PDF

Unlabelled: Purpose or Objective-The aim of the study is to evaluate the efficacy and safety of SBRT on detectable prostate bed recurrence in RT-naïve prostate cancer patients.

Materials And Methods: Eighty-six patients who underwent SBRT for macroscopic bed recurrence after prostatectomy were retrospectively included. Patients were treated based on mpMRI or choline/PSMA PET.

View Article and Find Full Text PDF

Background: The multi-centre two-stage SCALOP-2 trial (ISRCTN50083238) assessed whether dose escalation of consolidative chemoradiotherapy (CRT) or concurrent sensitization using the protease inhibitor nelfinavir improve outcomes in locally advanced pancreatic cancer (LAPC) following four cycles of gemcitabine/nab-paclitaxel.

Methods: In stage 1, the maximum tolerated dose (MTD) of nelfinavir concurrent with standard-dose CRT (50.4 Gy in 28 fractions) was identified from a cohort of 27 patients.

View Article and Find Full Text PDF

Introduction: The global need for antifungal stewardship is driven by spreading antimicrobial and antifungal resistance. Triazoles are the only oral and relatively well-tolerated class of antifungal medications, and usage is associated with acquired resistance and species replacement with intrinsically resistant organisms. On a per-patient basis, hematology patients are the largest inpatient consumers of antifungal drugs, but are also the most vulnerable to invasive fungal disease.

View Article and Find Full Text PDF

The combustion of coal in power plants releases significant amounts of polycyclic aromatic hydrocarbons (PAHs), which are highly toxic and carcinogenic. This study assesses the ecological and human health impacts of PAHs contamination from a coal-fired power plant over 8 years. The monitoring site selection considered the distance from the power plant and the prevailing wind direction in the investigated area.

View Article and Find Full Text PDF

Backbone and methyl side-chain resonance assignments of the Fab fragment of adalimumab.

Biomol NMR Assign

December 2024

Centre for Oncology, Radiopharmaceuticals and Research, Biologics and Radiotherapeutic Drugs Directorate, Health Canada, 251 Sir Frederick Banting Driveway, Ottawa, ON, K1A 0K9, Canada.

Article Synopsis
  • Adalimumab is a monoclonal antibody designed to inhibit TNF, which plays a key role in immune-related inflammatory diseases like rheumatoid arthritis.
  • The Fab fragment of adalimumab, weighing 48 kDa, was produced in E. coli using a method that allows for the incorporation of isotopes like deuterium and carbon-13.
  • This study presents nearly complete resonance assignments for the backbone of the polypeptide and the methyl groups of key amino acids (isoleucine, leucine, and valine).
View Article and Find Full Text PDF

Calcitonin gene-related peptide (CGRP) and adrenomedullin 2/intermedin (AM2/IMD) play important roles in several pathologies, including cardiovascular disease, migraine and cancer. The efficacy of drugs targeting CGRP signalling axis for the treatment of migraine patients is sometimes offset by side effects (e.g.

View Article and Find Full Text PDF

Recent Therapeutic Gene Editing Applications to Genetic Disorders.

Curr Issues Mol Biol

April 2024

Regulatory Research Division, Centre for Oncology, Radiopharmaceuticals and Research, Biologic and Radiopharmaceutical Drugs Directorate, Health Products and Food Branch, Health Canada, Ottawa, ON K1A 0K9, Canada.

Recent years have witnessed unprecedented progress in therapeutic gene editing, revolutionizing the approach to treating genetic disorders. In this comprehensive review, we discuss the progression of milestones leading to the emergence of the clustered regularly interspaced short palindromic repeats (CRISPR)-based technology as a powerful tool for precise and targeted modifications of the human genome. CRISPR-Cas9 nuclease, base editing, and prime editing have taken center stage, demonstrating remarkable precision and efficacy in targeted ex vivo and in vivo genomic modifications.

View Article and Find Full Text PDF
Article Synopsis
  • The calcitonin receptor-like receptor (CLR) is a protein that plays important roles in various health issues, including heart problems and cancer.
  • Researchers created a new method to find out which other proteins interact with CLR in human cells, discovering 37 new proteins that connect with it.
  • This study is a big step forward in understanding how CLR works in the body, and it opens the door for more research about it in different diseases.
View Article and Find Full Text PDF

Current status of bispecific antibodies and CAR-T therapies in multiple myeloma.

Int Immunopharmacol

June 2024

Lower Silesia Centre for Oncology, Pulmonology and Hematology in Wrocław, 53-439 Wroclaw, Poland; Department of Oncology and Hematology, Wroclaw University of Science and Technology, 50-370 Wrocław, Poland. Electronic address:

Multiple myeloma (MM), a malignancy of plasma cells, is an incurable disease that is characterized by the neoplastic proliferation of plasma cells leading to extensive skeletal destruction. This includes osteolytic lesions, osteopenia, and pathologic fractures. MM is clinically manifested through bone pain, renal insufficiency, hypercalcemia, anemia, and recurrent infections.

View Article and Find Full Text PDF

Aim: The study aims to report the feasibility and safety of palliative hypofractionated radiotherapy targeting macroscopic bladder tumors in a monocentric cohort of frail and elderly bladder cancer patients not eligible for curative treatments.

Methods: Patients who underwent hypofractionated radiotherapy to the gross disease or to the tumor bed after transurethral resection of bladder tumor from 2017 to 2021 at the European Institute of Oncology IRCCS, were retrospectively considered. Schedules of treatment were 30 and 25 Gy in 5 fractions (both every other day, and consecutive days).

View Article and Find Full Text PDF

Backbone and methyl side-chain resonance assignments of the single chain Fab fragment of trastuzumab.

Biomol NMR Assign

December 2024

Centre for Oncology, Radiopharmaceuticals and Research, Biologics and Radiotherapeutic Drugs Directorate, Health Canada, 251 Sir Frederick Banting Driveway, Ottawa, ON, K1A 0K9, Canada.

Trastuzumab is a therapeutic monoclonal antibody developed to target human epidermal growth factor receptor 2 (HER2) present at higher levels in early cancers. Here we report the near complete resonance assignment of trastuzumab-scFab fragment backbone and the methyl groups of isoleucine, leucine and valine residues, as well as their stereo-assignments. The antibody fragment was produced using a single chain approach in Escherichia coli.

View Article and Find Full Text PDF

Blood microbial signatures associated with mortality in patients with sepsis: A pilot study.

Heliyon

April 2024

Department of Anaesthesia and Intensive Care and Peter Hung Pain Research Institute, The Chinese University of Hong Kong, Hong Kong, China.

Sepsis is a life-threatening illness caused by the dysregulated host response to infection. Nevertheless, our current knowledge of the microbial landscape in the blood of septic patients is still limited. Next-generation sequencing (NGS) is a sensitive method to quantitatively characterize microbiomes at various sites of the human body.

View Article and Find Full Text PDF

Anthropogenic activities are leaving lots of chemical footprints on the soil. It alters the physiochemical characteristics of the soil thereby modifying the natural soil microbiome. The prevalence of antimicrobial-resistance microbes in polluted soil has gained attention due to its obvious public health risks.

View Article and Find Full Text PDF

The immunoregulatory effects of total glucosides of paeony in autoimmune diseases.

J Leukoc Biol

April 2024

Department of Pathology, Faculty of Medicine and HKU Shenzhen Hospital, The University of Hong Kong, Hong Kong, China.

Article Synopsis
  • Total glucoside of paeonia (TGP) and its active component paeoniflorin, derived from the herb Paeonia Lactiflora, demonstrate strong immunomodulatory properties.
  • TGP effectively reduces inflammation and slows disease progression in multiple autoimmune diseases like rheumatoid arthritis and lupus.
  • It works on various immune cells by influencing their functions through key intracellular signaling pathways, showing promising clinical results with few side effects.
View Article and Find Full Text PDF
Article Synopsis
  • Chemotherapy is the primary treatment for triple-negative breast cancer (TNBC), and there's growing interest in targeting CD73 to enhance immunotherapy effectiveness, as it suppresses anti-cancer immunity.
  • CD73 carries a dual role in promoting tumor survival by both inhibiting immune response and enabling the growth of cancer stem cells (CSCs), which may lead to tumor relapse after treatment.
  • Researchers conducted in silico screening of compounds and found that quercetin and luteolin, when combined with the chemotherapy drug paclitaxel, effectively downregulated pathways associated with CD73 and CSCs, indicating a potential strategy for improved TNBC treatment outcomes.*
View Article and Find Full Text PDF

Background: The optimal timing of radiotherapy (RT) after radical prostatectomy for prostate cancer has been uncertain. RADICALS-RT compared efficacy and safety of adjuvant RT versus an observation policy with salvage RT for prostate-specific antigen (PSA) failure.

Patients And Methods: RADICALS-RT was a randomised controlled trial enrolling patients with ≥1 risk factor (pT3/4, Gleason 7-10, positive margins, preoperative PSA≥10 ng/ml) for recurrence after radical prostatectomy.

View Article and Find Full Text PDF
Article Synopsis
  • * Researchers used advanced RNA-sequencing techniques on tumor samples taken from patients after four weeks of IDHi treatment to examine cellular changes.
  • * Findings reveal that IDHi promotes differentiation of tumor cells toward a specific brain cell type (astrocytes), reduces stem-like cells, and highlights a mutation (NOTCH1) that may hinder this differentiation and affect treatment response.
View Article and Find Full Text PDF

Real-world data in clinical practice are needed to confirm the efficacy and safety that ibrutinib has demonstrated in clinical trials of patients with chronic lymphocytic leukemia (CLL). We described the real-world persistence rate, patterns of use, and clinical outcomes in 309 patients with CLL receiving single-agent ibrutinib in first line (1L, = 118), 2L ( = 127) and ≥3L ( = 64) in the prospective, real-world, Italian EVIdeNCE study. After a median follow-up of 23.

View Article and Find Full Text PDF